Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc. (TARS), sold 8,872 shares at $30.60 ($271K) on 2024-03-18, disclosed to the SEC on 2024-03-19.
Open-market sale of $271k TARS by General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.60 | 4,436 | $136K | 50.0% |
| 2 | $30.60 | 4,436 | $136K | 50.0% |
| Total | $30.60 avg | 8,872 | $271K | 100% |
| Filing → |
| TARS | SELL | 2023-12-01 | $273K | — | Filing → |
| TARS | SELL | 2023-03-23 | $14K | — | Filing → |
| TARS | SELL | 2023-03-21 | $9K | — | Filing → |